Convergence of Science - An overview of how the use peptides differentiates from the use of standard antibodies with reference to specificity, sensitivity, speed, and accuracy.
TruCov - An introduction to Neuome Peptides’ platform technology (InstaDetect), using our peptide-based COVID-19 testing devices as an illustrative example.
TruHeart - An overview of the cardiac biomarker assay platform, TruHeart, as an illustrative example of the adaptability of InstaDetect.
Clinical Trial Plan, Product Progression and Regulatory Approvals - An update on the ongoing and upcoming clinical trials, product progression and regulatory approvals.
Revenue Potential: Neuome Peptides revenue potential with reference to the market size of the relevant biomarkers for its current and most immediate pipeline products.
Fundraising Objectives:An overview of the fundraising objectives in this round, as well as our intended use of funds.